Divi’s Laboratories Limited (DIVISLAB): Basic Information
Full Name: Divi’s Laboratories Limited
Type: Public Sector Pharmaceutical Company
Headquarters: Hyderabad, Telangana, India
Founded: 1990
Founder: Dr. Murali K. Divi
Chairman: Dr. Murali K. Divi (as of 2025)
CEO & MD: Kiran S. Divi (as of 2025)
Tagline: Innovating for a Healthier Tomorrow
Industry: Pharmaceuticals and Nutraceuticals
Products and Services:
- Active Pharmaceutical Ingredients (APIs): High-quality APIs for global markets
- Intermediates: Critical raw materials for pharmaceutical formulations
- Nutraceuticals: Health supplements and wellness products
- Custom Synthesis: Contract manufacturing for leading global pharma companies
Key Financial Metrics (as of 2024):
- Revenue: ₹10,500 crore (approx.)
- Net Profit: ₹2,200 crore (approx.)
- Market Capitalization: ₹90,000 crore (approx.)
Global Presence:
- Exports to over 95 countries worldwide
- Manufacturing facilities approved by USFDA, EMEA, and other regulatory bodies
- Strong relationships with major global pharmaceutical companies
Recognition:
- Leader in the production of high-quality APIs
- Recognized for sustainable practices and eco-friendly manufacturing
- Awarded for excellence in R&D and innovation
Divi’s Laboratories Limited (DIVISLAB) is a globally recognized pharmaceutical company specializing in the development and production of high-quality active pharmaceutical ingredients (APIs) and intermediates. Established in 1990 and headquartered in Hyderabad, India, Divi’s serves a wide range of pharmaceutical and nutraceutical clients across over 95 countries. With a commitment to innovation and sustainable practices, the company has become a trusted partner for major global pharmaceutical firms, offering custom synthesis solutions and cutting-edge products.
Much like Reliance’s transformative contributions to telecom and energy, Divi’s Laboratories has revolutionized the pharmaceutical supply chain with its superior quality and efficient manufacturing processes. Its state-of-the-art facilities and eco-friendly initiatives have set industry benchmarks, ensuring compliance with stringent global regulations. Divi’s continues to lead the way in pharmaceutical innovation, focusing on delivering solutions that enhance health and well-being across the globe.